Zobrazeno 1 - 10
of 298
pro vyhledávání: '"Sandra L Kane"'
Autor:
Xiaotong Li, Xinlei Chen, David T Huang, Chung-Chou H Chang, John Kellum, Ivan E Saraiva, Natsumi Hamahata, Sandra L Kane-Gill, Ryan M Rivosecchi, Sruti Shiva, Thomas D Nolin, John Minturn, Hernando Gómez
Publikováno v:
BMJ Open, Vol 14, Iss 4 (2024)
Introduction Acute kidney injury (AKI) is a common complication of sepsis associated with increased risk of death. Preclinical data and observational human studies suggest that activation of AMP-activated protein kinase, an ubiquitous master regulato
Externí odkaz:
https://doaj.org/article/ca1a7399ecd546d8bb89af1605429d21
Autor:
Katie E. Cardone, Rebecca Maxson, Katherine H. Cho, Joseph M. Davis, Wasim S. El Nekidy, Sandra L. Kane-Gill, Anusha McNamara, Lori Wazny, Lana Wong, Marisa Battistella
Publikováno v:
Kidney Medicine, Vol 4, Iss 8, Pp 100509- (2022)
Patients with kidney disease represent a medically complex group of patients with high medication burdens that could benefit from clinical pharmacy services as part of the interdisciplinary care team to optimize medication use. The “Advancing Ameri
Externí odkaz:
https://doaj.org/article/e779857bf0684cf1bb85c66e55fffdd3
Autor:
Heather Meissen, DNP, ACNP-BC, CCRN, FCCM, Michelle Ng Gong, MD, MS, An-Kwok Ian Wong, MD, PhD, Jerry J. Zimmerman, MD, PhD, FCCM, Nalini Nadkarni, PhD, Sandra L. Kane-Gil, PharmD, MSc, FCCM, Javier Amador-Castaneda, BS, RRT, Heatherlee Bailey, MD, FCCM, Samuel M. Brown, MD, MS, FCCM, Ashley D. DePriest, LD, MS, RD, CNSC, Ifeoma Mary Eche, PharmD, BCCCP, FCCM, Mayur Narayan, MD, MPH, MBA, MHPE, FCCM, Jose Javier Provencio, MD, FCCM, Nneka O. Sederstrom, MPH, PhD, FCCM, Jonathan Sevransky, MD, MHS, FCCM, Jordan Tremper, MHA, BSN, RN, CCRN-K, Rebecca A. Aslakson, MD, PhD, FCCM, FAAHPM, written on behalf of the Society of Critical Care Medicine’s Future of Critical Care Taskforce
Publikováno v:
Critical Care Explorations, Vol 4, Iss 3, p e0659 (2022)
While technological innovations are the invariable crux of speculation about the future of critical care, they cannot replace the clinician at the bedside. This article summarizes the work of the Society of Critical Care Medicine–appointed multipro
Externí odkaz:
https://doaj.org/article/6702f303ec9841c8bbb465aed73fa3bd
Autor:
Alexander Zarbock, Mitra K. Nadim, Peter Pickkers, Hernando Gomez, Samira Bell, Michael Joannidis, Kianoush Kashani, Jay L. Koyner, Neesh Pannu, Melanie Meersch, Thiago Reis, Thomas Rimmelé, Sean M. Bagshaw, Rinaldo Bellomo, Vicenzo Cantaluppi, Akash Deep, Silvia De Rosa, Xose Perez-Fernandez, Faeq Husain-Syed, Sandra L. Kane-Gill, Yvelynne Kelly, Ravindra L. Mehta, Patrick T. Murray, Marlies Ostermann, John Prowle, Zaccaria Ricci, Emily J. See, Antoine Schneider, Danielle E. Soranno, Ashita Tolwani, Gianluca Villa, Claudio Ronco, Lui G. Forni
Publikováno v:
Nature Reviews. Nephrology, 19, 401-417
Nature Reviews. Nephrology, 19, 6, pp. 401-417
Nature Reviews. Nephrology, 19, 6, pp. 401-417
Item does not contain fulltext Sepsis-associated acute kidney injury (SA-AKI) is common in critically ill patients and is strongly associated with adverse outcomes, including an increased risk of chronic kidney disease, cardiovascular events and deat
Autor:
Sandra, Kane-Gill, Victoria L, Williams, Lara M, Groetzinger, Pamela L, Smithburger, Allison, Imhoff, Colleen M, Culley, Raghavan, Murugan, John A, Kellum, Sandra L, Kane-Gill
Publikováno v:
American Journal of Health-System Pharmacy. 80:423-429
Purpose Traditional methods used to evaluate changes in kidney function to identify acute kidney injury (AKI) have significant limitations. Damage biomarkers can identify patients at risk for AKI prior to changes in kidney function. While clinical tr
Autor:
Victoria L. Williams, Pamela L. Smithburger, Allison N. Imhoff, Lara M. Groetzinger, Colleen M. Culley, Clayton X. Burke, Raghavan Murugan, Phillip E. Lamberty, Mujtaba Mahmud, Neal J. Benedict, John A. Kellum, Sandra L. Kane-Gill
Publikováno v:
Annals of Pharmacotherapy. 57:408-415
Background: Damage biomarkers are helpful in early identification of patients who are at risk of developing acute kidney injury (AKI). Investigations are ongoing to identify the optimal role of stress/damage biomarkers in clinical practice regarding
Autor:
Britney A. Stottlemyer, Kaleab Z. Abebe, Paul M. Palevsky, Linda Fried, Ivonne H. Schulman, Chirag R. Parikh, Emilio Poggio, Edward D. Siew, Orlando M. Gutierrez, Edward Horwitz, Matthew R. Weir, F. Perry Wilson, Sandra L. Kane-Gill
Publikováno v:
Drug Safety.
Autor:
Matthew P. Gray, Erin F. Barreto, Diana J. Schreier, John A. Kellum, Kangho Suh, Kianoush B. Kashani, Andrew D. Rule, Sandra L. Kane-Gill
Publikováno v:
Drug Safety. 45:389-398
Autor:
Galen E. Switzer, Chethan M. Puttarajappa, Sandra L. Kane-Gill, Linda F. Fried, Kaleab Z. Abebe, John A. Kellum, Manisha Jhamb, Jessica G. Bruce, Vidya Kuniyil, Paul T. Conway, Richard Knight, John Murphy, Paul M. Palevsky
Publikováno v:
Kidney360
BACKGROUND: Investigations of health-related quality of life (HRQoL) in AKI have been limited in number, size, and domains assessed. We surveyed AKI survivors to describe the range of HRQoL AKI-related experiences and examined potential differences i
Autor:
Mitchell S. Buckley, Brandon K. Martinez, Sumit K. Agarwal, Ivan A. Komerdelj, Pooja Rangan, Paul A. D'Alessio, Delia S. Ziadat, Sandra L. Kane-Gill, Nicole C. Tinta, Melanie J. Yerondopoulos, Emir Kobic
Publikováno v:
Journal of Critical Care. 67:134-140
Purpose The risk of acute kidney injury (AKI) associated with concomitant vancomycin and piperacillin/tazobactam in the intensive care unit (ICU) remains controversial. The aim of this study was to compare the AKI incidence associated with concomitan